A case report demonstrates the effectiveness of infliximab in hemodialysis patients with inflammatory bowel disease, suggesting tailored treatment approaches.
This case clearly illustrates the impact of comorbidities and the importance of a multidisciplinary approach in the management of elderly patients with inflammatory bowel disease. We demonstrated that infliximab therapy is effective and safe in the presence of concomitant severe inflammatory bowel disease and end-stage renal disease requiring hemodialysis.
No takes yet. Share an insight, caveat, or question.
Balogh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: